UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 72

Sortiert nach

Digital Twins for Multiple Sclerosis

Frontiers in immunology, 2021-05, Vol.12, p.669811-669811

2021

Link zum Volltext

Verfügbarkeit prüfen

Therapy satisfaction and adherence in patients with relapsing–remitting multiple sclerosis: the THEPA-MS survey

Therapeutic advances in neurological disorders, 2016-07, Vol.9 (4), p.250-263

2016

Link zum Volltext

Verfügbarkeit prüfen

S1P receptor modulators and the cardiovascular autonomic nervous system in multiple sclerosis: a narrative review

Therapeutic Advances in Neurological Disorders, 2022-01, Vol.15, p.175628642211331-17562864221133163

2022

Link zum Volltext

Verfügbarkeit prüfen

Data Collection in Multiple Sclerosis: The MSDS Approach

Frontiers in neurology, 2020-06, Vol.11, p.445-445

2020

Link zum Volltext

Verfügbarkeit prüfen

Drug and Neurofilament Levels in Serum and Breastmilk of Women With Multiple Sclerosis Exposed to Natalizumab During Pregnancy and Lactation

Frontiers in immunology, 2021-08, Vol.12, p.715195-715195

2021

Link zum Volltext

Verfügbarkeit prüfen

Digital Innovation in Multiple Sclerosis Management

Brain sciences, 2021-12, Vol.12 (1), p.40

2021

Link zum Volltext

Verfügbarkeit prüfen

Fingolimod additionally acts as immunomodulator focused on the innate immune system beyond its prominent effects on lymphocyte recirculation

Journal of neuroinflammation, 2017-02, Vol.14 (1), p.41-41, Article 41

2017

Link zum Volltext

Verfügbarkeit prüfen

Real World Lab Data: Patterns of Lymphocyte Counts in Fingolimod Treated Patients

Frontiers in immunology, 2018-11, Vol.9, p.2669-2669

2018

Link zum Volltext

Verfügbarkeit prüfen

Influence of Pre-Analytic Conditions on Quantity of Lymphocytes

International journal of molecular sciences, 2023-09, Vol.24 (17), p.13479

2023

Link zum Volltext

Verfügbarkeit prüfen

Electronic Health Interventions in the Case of Multiple Sclerosis: From Theory to Practice

Brain sciences, 2021-02, Vol.11 (2), p.180

2021

Link zum Volltext

Verfügbarkeit prüfen

Event-Driven Immunoprofiling Predicts Return of Disease Activity in Alemtuzumab-Treated Multiple Sclerosis

Frontiers in immunology, 2020-01, Vol.11, p.56-56

2020

Link zum Volltext

Verfügbarkeit prüfen

Differential effects of selective versus unselective sphingosine 1-phosphate receptor modulators on T- and B-cell response to SARS-CoV-2 vaccination

Multiple sclerosis, 2023-12, Vol.29 (14), p.1849-1859

2023

Link zum Volltext

Verfügbarkeit prüfen

Fampridine response in MS patients with gait impairment in a real-world setting: Need for new response criteria?

Multiple sclerosis, 2018-09, Vol.24 (10), p.1337-1346

2018

Link zum Volltext

Verfügbarkeit prüfen

Correction to: Differentiating societal costs of disability worsening in multiple sclerosis

Journal of neurology, 2020-04, Vol.267 (4), p.1043-1044

2020

Link zum Volltext

Verfügbarkeit prüfen

Fingolimod Leads to Immediate Immunological Changes Within 6 h After First Administration

Frontiers in neurology, 2020-05, Vol.11, p.391-391

2020

Link zum Volltext

Verfügbarkeit prüfen

Gender disparities in health resource utilization in patients with relapsing–remitting multiple sclerosis: a prospective longitudinal real-world study with more than 2000 patients

Therapeutic advances in neurological disorders, 2020, Vol.13, p.1756286420960274-1756286420960274

2020

Link zum Volltext

Verfügbarkeit prüfen

Real-World Lab Data in Natalizumab Treated Multiple Sclerosis Patients Up to 6 Years Long-Term Follow Up

Frontiers in neurology, 2018-12, Vol.9, p.1071-1071

2018

Link zum Volltext

Verfügbarkeit prüfen

NVX-CoV2373-induced T- and B-cellular immunity in immunosuppressed people with multiple sclerosis that failed to respond to mRNA and viral vector SARS-CoV-2 vaccines

Frontiers in immunology, 2023, Vol.14, p.1081933-1081933

2023

Link zum Volltext

Verfügbarkeit prüfen

Influence of exercise on quantity and deformability of immune cells in multiple sclerosis

Frontiers in neurology, 2023-05, Vol.14, p.1148106-1148106

2023

Link zum Volltext

Verfügbarkeit prüfen

The Dresden Protocol for Multidimensional Walking Assessment (DMWA) in Clinical Practice

Frontiers in neuroscience, 2020-10, Vol.14, p.582046-582046

2020

Link zum Volltext

Verfügbarkeit prüfen

Digital Biomarkers in Multiple Sclerosis

Brain sciences, 2021-11, Vol.11 (11), p.1519

2021

Link zum Volltext

Verfügbarkeit prüfen

An Innovative Technique to Assess Spontaneous Baroreflex Sensitivity with Short Data Segments: Multiple Trigonometric Regressive Spectral Analysis

Frontiers in physiology, 2018-01, Vol.9, p.10-10

2018

Link zum Volltext

Verfügbarkeit prüfen

Sudomotor Testing of Diabetes Polyneuropathy

Frontiers in neurology, 2018-09, Vol.9, p.803-803

2018

Link zum Volltext

Verfügbarkeit prüfen

Improving Digital Patient Care: Lessons Learned from Patient-Reported and Expert-Reported Experience Measures for the Clinical Practice of Multidimensional Walking Assessment

Brain sciences, 2021-06, Vol.11 (6), p.786

2021

Link zum Volltext

Verfügbarkeit prüfen

Nonwalking response to fampridine in patients with multiple sclerosis in a real-world setting

Therapeutic advances in chronic disease, 2019, Vol.10, p.2040622319835136-2040622319835136

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 72

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(58)

Publikationsform

Sprache

Englisch
(62)
Deutsch
(10)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Digital Twins for Multiple Sclerosis

Therapy satisfaction and adherence in patients with relapsing–remitting multiple sclerosis: the THEPA-MS survey

S1P receptor modulators and the cardiovascular autonomic nervous system in multiple sclerosis: a narrative review

Data Collection in Multiple Sclerosis: The MSDS Approach

Drug and Neurofilament Levels in Serum and Breastmilk of Women With Multiple Sclerosis Exposed to Natalizumab During Pregnancy and Lactation

Digital Innovation in Multiple Sclerosis Management

Fingolimod additionally acts as immunomodulator focused on the innate immune system beyond its prominent effects on lymphocyte recirculation

Real World Lab Data: Patterns of Lymphocyte Counts in Fingolimod Treated Patients

Influence of Pre-Analytic Conditions on Quantity of Lymphocytes

Electronic Health Interventions in the Case of Multiple Sclerosis: From Theory to Practice

Event-Driven Immunoprofiling Predicts Return of Disease Activity in Alemtuzumab-Treated Multiple Sclerosis

Differential effects of selective versus unselective sphingosine 1-phosphate receptor modulators on T- and B-cell response to SARS-CoV-2 vaccination

Fampridine response in MS patients with gait impairment in a real-world setting: Need for new response criteria?

Correction to: Differentiating societal costs of disability worsening in multiple sclerosis

Fingolimod Leads to Immediate Immunological Changes Within 6 h After First Administration

Gender disparities in health resource utilization in patients with relapsing–remitting multiple sclerosis: a prospective longitudinal real-world study with more than 2000 patients

Real-World Lab Data in Natalizumab Treated Multiple Sclerosis Patients Up to 6 Years Long-Term Follow Up

NVX-CoV2373-induced T- and B-cellular immunity in immunosuppressed people with multiple sclerosis that failed to respond to mRNA and viral vector SARS-CoV-2 vaccines

Influence of exercise on quantity and deformability of immune cells in multiple sclerosis

The Dresden Protocol for Multidimensional Walking Assessment (DMWA) in Clinical Practice

Digital Biomarkers in Multiple Sclerosis

An Innovative Technique to Assess Spontaneous Baroreflex Sensitivity with Short Data Segments: Multiple Trigonometric Regressive Spectral Analysis

Sudomotor Testing of Diabetes Polyneuropathy

Improving Digital Patient Care: Lessons Learned from Patient-Reported and Expert-Reported Experience Measures for the Clinical Practice of Multidimensional Walking Assessment

Nonwalking response to fampridine in patients with multiple sclerosis in a real-world setting

Suchergebnisse filtern